Insiders Lineage Cell Therapeutics, Inc.

Equities

LCTX

US53566P1093

Real-time Estimate Cboe BZX Other stock markets 15:30:30 16/05/2024 BST			5-day change	1st Jan Change
1.085 ^USD	-0.46%		-5.93%	+1.83%

05-09	Transcript : Lineage Cell Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024
05-09	Earnings Flash (LCTX) LINEAGE CELL THERAPEUTICS Reports Q1 Revenue $1.4M, vs. Street Est of $1.36M	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lineage Cell Therapeutics, Inc. Announces Changes to Board of Directors	04-29	CI
Lineage Cell Therapeutics Names Jill Howe Finance Chief	31/10/22	MT
Lineage Cell Therapeutics, Inc Appoints Jill A. Howe as Chief Financial Officer, Effective November 14, 2022	31/10/22	CI
Lineage Cell Therapeutics, Inc. Announces Management Changes	07/07/22	CI
Insider Sell: Lineage Cell Therapeutics	31/12/21	MT
Lineage Cell Therapeutics, Inc. Appoints George A. Samuel III as General Counsel and Corporate Secretary	01/09/21	CI
Lineage Cell Therapeutics, Inc. Appoints Kevin L. Cook as CFO	12/08/21	CI
Insider Trends: Lineage Cell Therapeutics Insider Exercises Options Derivative Securities, Sells for Taxes and Self, Selling Trend Unaffected	30/06/21	MT
Lineage Cell Therapeutics, Inc. Announces Executive Changes, Effective June 21, 2021	16/06/21	CI
Lineage Cell Therapeutics, Inc. Announces Appointment of Anula Jayasuriya to its Board of Directors	05/05/21	CI
Lineage Cell Therapeutics, Inc. Announces Appointment of Dipti Amin to Its Board of Directors	22/04/21	CI
Lineage Cell Therapeutics : Announces Vitelliform Maculopathy Patient Treated With OpRegen® Under Named Patient Compassionate Use	29/03/21	BU
Lineage Cell Therapeutics, Inc. Announces Resignation of Chase C. Leavitt as General Counsel and Corporate Secretary, Effective April 7, 2021	26/03/21	CI
Lineage Cell Therapeutics, Inc. Announces Resignation of Edward D. Wirth as Chief Medical Officer, Effective from December 15, 2019	18/10/19	CI
BioTime, Inc. will Change its Name to Lineage Cell Therapeutics, Inc	12/08/19	CI
Biotime, Inc. Announces the Resignation of Cavan Redmond from Board of Directors	05/07/19	CI
BioTime, Inc. Appoints Chase C. Leavitt as General Counsel and Corporate Secretary	22/05/19	CI
BioTime, Inc. Appoints Dr. Ed Wirth as Chief Medical Officer	14/03/19	CI
BioTime Inc. Appoints Don M. Bailey to Board of Directors	08/03/19	CI
BioTime, Inc. Appoints Brandi L. Roberts as Chief Financial Officer and Senior Vice President, Finance	04/01/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Lineage Cell Therapeutics, Inc.

Equities

LCTX

US53566P1093

Insiders

Filters